LoginRegister
    Cipla API facility in Bengaluru gets EIR from USFDACipla API facility in Bengaluru gets EIR from USFDA
    Torrent Pharma expands recall of Losartan tablets in US over carcinogen impurityTorrent Pharma expands recall of Losartan tablets in US over carcinogen impurity
    CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patientsCDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing...
    Unichem Labs API facility in Kolhapur clears CGMP surveillance by USFDAUnichem Labs API facility in Kolhapur clears CGMP surveillance by USFDA
    Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPDCipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD
    Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at BengaluruSiemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru
    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster dose to sectorHealthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster...
    Condom sales down by 8 percent, estimates Industry sourcesCondom sales down by 8 percent, estimates Industry sources
    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics ActRegulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act
    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis BiopharmaStrides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis...
    Lupin gets USFDA nod for generic equivalent of UNITHROID to treat thyroidLupin gets USFDA nod for generic equivalent of UNITHROID to treat thyroid
    AstraZeneca, Ironwood Pharma amend IBS-C drug deal in ChinaAstraZeneca, Ironwood Pharma amend IBS-C drug deal in China
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X